News

For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...
GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...
Instant ramen maker Nissin Foods is leveraging the buzz around GLP-1s to launch in the US a trio of decadent tasting frozen ...
Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for ...
We view a Medifast revitalization as hinging on a steep coach network inflection. Read why we think MED stock becomes a core ...
Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...